Cancer and pregnancy: recent developments.
OBJECTIVE
Breast carcinoma, cervical dysplasia and cervical carcinoma are some of the most common forms of precancerous and malignant changes seen in pregnancy due to their prevalence in reproductive age women. The impact of pregnancy on these diseases is complex and needs to be carefully considered for appropriate clinical management.


RESULTS
Recent studies indicate a relationship between hormone levels during pregnancy and subsequent breast cancer risk. For women who have already been diagnosed with breast cancer, retrospective studies show no adverse outcomes on maternal mortality with subsequent pregnancy. Prospective studies are needed to further elucidate these relationships. Recent research evaluating human papilloma virus in pregnant women indicates a similar prevalence of disease among pregnant and nonpregnant patients. Increased rates of human papilloma virus clearance postpartum may be related to an increased immune response within the cervix secondary to the trauma of labor. For women with early stage cervical cancer desiring to preserve future fertility, new trends in treatment allow for preservation of reproductive function. Few recent studies have been conducted regarding the use of chemotherapy during pregnancy, but one study reports increased rates of prematurity after the use of chemotherapy.


CONCLUSIONS
Continued research is needed regarding the management of breast and cervical cancer during pregnancy in order to optimize treatments and to further our understanding of these disease processes.
Ward
Renée M
RM
Department of Gynecology and Obstetrics, The John Hopkins Medical Institutions, Baltimore, Maryland 21287-1248, USA.
Bristow
Robert E
RE
D001943:Breast Neoplasms / Q000150:complications* / Q000628:therapy; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy; D011256:Pregnancy Outcome; D002578:Uterine Cervical Dysplasia / Q000150:complications* / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000150:complications* / Q000628:therapy